For the Inventor, By the Inventor

Enter assignee name

Emeryville, CA, United States of America

Cetus Oncology Corporation

USPTO Granted Patents = 28

Forward Citations = 1,151

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

Danute E Nitecki (6 out of 31 patents)

Peter Ralph (4 out of 29 patents)

Robert F Halenbeck (4 out of 40 patents)

4. Michael Kriegler (4 out of 21 patents)

5. Kirston E Koths (3 out of 44 patents)

6. David B Ring (2 out of 33 patents)

7. Mazie Yee Coyne (2 out of 10 patents)

8. Ernest S Kawasaki (2 out of 14 patents)

9. George A Martin (2 out of 27 patents)

10. Martha B Ladner (2 out of 14 patents)

11. Arthur E Frankel (2 out of 9 patents)

12. Margaret Moreland (2 out of 17 patents)

13. Robert Zimmerman (2 out of 12 patents)

14. Hing C Wong (1 out of 104 patents)

15. Ian J Mohr (1 out of 13 patents)

28 patents: Sort by Forward Citations

1. 6238891 - Method of increasing product expression through solute stress (2001-05-29),

2. 5639593 - Method for determining TNF (1997-06-17),

3. 5629197 - Monoclonal anti-human breast cancer antibodies (1997-05-13),

4. 5591827 - Interleukin-6 receptor antagonists (1997-01-07),

5. 5573930 - DNA encoding various forms of colony stimulating factor-1 (1996-11-12),

6. 5556620 - Use of recombinant colony stimulating factor-1 to enhance wound healing (1996-09-17),

7. 5545518 - Assay for determinig TNF or IL-1 convertase activity (1996-08-13),

8. 5538868 - Recombinant ricin toxin fragments (1996-07-23),

9. 5508031 - Method for treating biological damage using a free-radial scavenger and (1996-04-16),

10. 5503841 - Human IL-2 as a vaccine adjuvant (1996-04-02),

11. 5491065 - Monoclonal antibodies that bind to and neutralize dimeric but not (1996-02-13),

12. 5470569 - Recombinant colony stimulating factor-1 (1995-11-28),

13. 5464936 - Compositions for identification of papillomavirus replication inhibitors (1995-11-07),

14. 5455330 - Interleukin-1 antagonist and uses thereof (1995-10-03),

15. 5425940 - Combination therapy using interleukin-2 and tumor necrosis factor (1995-06-20),

Cetus Oncology Corporation is a leading biopharmaceutical company specializing in the development and commercialization of innovative cancer treatments. Our mission is to improve the lives of cancer patients by delivering targeted therapies that effectively combat the disease with minimal side effects. With a strong focus on research and development, we are dedicated to advancing the field of oncology and bringing hope to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

28 Patents

#21 in Emeryville, CA

#2,763 in California

#11,597 in US

#22,547 in the World

Emeryville, CA, United States of America

Cetus Oncology Corporation

Forward Citations = 1,151

54 inventors:

Danute E Nitecki (6 out of 31 patents)

Peter Ralph (4 out of 29 patents)

Robert F Halenbeck (4 out of 40 patents)

4. Michael Kriegler (4 out of 21 patents)

5. Kirston E Koths (3 out of 44 patents)

Please report any incorrect information to support@idiyas.com

Loading…